logo True scholar network
Back to Top
Visit Website Disclaimer

JAMA Oncology (JAMA O)

Publisher :

American Medical Association

Scopus Profile
Peer reviewed only
Scopus Profile
Open Access
  • Oncology
  • Medicine
  • Cancer Research

    • +2

e-ISSN :

2374-2445

Issue Frequency :

Monthly

Impact Factor :

28.4

p-ISSN :

2374-2437

Est. Year :

2015

Mobile :

8002622350

Country :

United States

Language :

English

APC :

YES

Impact Factor Assignee :

Google Scholar

Email :

jamaonc@jamanetwork.org

Journal Descriptions

JAMA Oncology is an international peer-reviewed journal and the definitive journal for scientists, clinicians, and trainees in the field of oncology. JAMA Oncology is a member of the JAMA Network, a consortium of peer-reviewed, general medical and specialty publications. JAMA Oncology is published online weekly, every Thursday, and in 12 print/online issues a year. The journal receives more than 6.4 million annual article views and downloads. Without any author fees, all research articles are made free access online 12 months after publication on the website. In addition, the online version is freely available or nearly so to institutions in developing countries through the World Health Organization's HINARI program.


JAMA Oncology (JAMA O) is :

International, Peer-Reviewed, Open Access, Refereed, Oncology, Medicine, Cancer Research, Molecular Biology, Biochemistry , Online or Print, Monthly Journal

UGC Approved, ISSN Approved: P-ISSN - 2374-2437, E-ISSN - 2374-2445, Established in - 2015, Impact Factor - 28.4

Not Provide Crossref DOI

Indexed in Scopus

Not indexed in WoS, DOAJ, PubMed, UGC CARE

Indexing

Scopus Profile
Scopus
Scopus Profile
ISSN Portal
Scopus Profile
National Library of Medicine (NLM)

+1 More

Publications of JAMA O

Original Article
  • dott image Amanda Ramos da Cunha
  • dott image September, 2023

The Global, Regional, and National Burden of Adult Lip, Oral, and Pharyngeal Cancer in 204 Countries and Territories

Importance Lip, oral, and pharyngeal cancers are important contributors to cancer burden worldwide, and a comprehensive evaluation of their burden globally, regionally, and nationally is cr...

Original Article
  • dott image Jonathan M. Kocarnik
  • dott image December, 2021

Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 201...

Importance The Global Burden of Diseases, Injuries, and Risk Factors Study 2019 (GBD 2019) provided systematic estimates of incidence, morbidity, and mortality to inform local and internati...

Research Article
  • dott image October, 2019

Circulating Tumor DNA Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon Cancer

Importance Adjuvant chemotherapy in patients with stage III colon cancer prevents recurrence by eradicating minimal residual disease. However, which patients remain at high risk of recurren...

Establish Your Own Journal Without the Expense!

OJSCloud offers a complete, free setup to get you publishing.

Start Your Free Journal!
free profile